IPOBoutique Brief: 1.20.2015 — Flood of IPOs set terms

We expected 2015 to be a robust year for IPOs and were somewhat surprised that more deals did not come to market or set terms before MLK Day.  However, that surprise was greeted with eight companies releasing official filings to the SEC setting terms for their respective IPOs.

• Avinger (Nasdaq: AVGR) – Trade Date: Week of 1/26: 4.6m shares at $12-$14
• Flex Pharma (Nasdaq: FLKS) – Trade Date: 1/29: 4.6m shares at $12-$14
• Spark Therapeutics (Nasdaq: ONCE) – Trade Date: 1/30: 5.5m shares at $15-$17
• Shake Shack (NYSE: SHAK) – Trade Date: 1/30: 5m shares at $14-$16
• InfraREIT (NYSE: HIFR) – Trade Date: 1/30: 20m shares at $19-$21
• Infraredx (Nasdaq: REDX) – Trade Date: 1/30: 4m shares at $13-$15
• Tracon Pharmaceuticals (Nasdaq: TCON) – TD: 1/30: 3.6m shares at $12-$14
• Advanced Accelerator Applications S.A. (Nasdaq: AAAP): TD 2/5 at $13-$15

These eight deals are in addition to these four companies who set terms last week:

• Zosano Pharma (Nasdaq: ZSAN) – TD: Week of 1/26: 3m shares at $10-$12
• Presbia plc (Nasdaq: LENS) – Trade Date: 1/28: 4.2m shares at $11-$13
• Ascendis Pharma A/S (Nasdaq: ASND) – Trade Date: 1/29: 5m shares at $16-$18
• Entellus Medical (Nasdaq: ENTL) — Trade Date: 1/29: 4.4m shares at $15-$17

Are you looking for an edge on the IPO market? Now is a GREAT time to subscribe with IPO Boutique. Money in the IPO market can not only be made by indicating for the very, best deals…but also by staying away from the weak ones. Senior managing partner Scott Sweet has more than 40 years of experience in the IPO market and has maintained an extremely strong track record. If you have inquiries about our service, please do not hesitate to contact us.